Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

BE 10988

Known as: 4-Thiazolecarboxamide, 2-(5-amino-4,7-dihydro-1-methyl-4,7-dioxo-1H-indol-3-yl)-, BE-10988 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A large number of indolyl-4-azaindolyl thiazoles, nortopsentin analogues, were conveniently synthesized. The antiproliferative… Expand
2011
2011
During our careful surveillance of unregulated drugs in January to February 2011, we found two new compounds used as adulterants… Expand
  • figure 1
  • figure 2
  • figure 4
  • table 1
  • figure 5
Review
2009
Review
2009
Structurally related secondary products are rather rarely shared by organisms from different kingdoms. Consequently, the… Expand
2008
2008
The biosynthetic origin of the tumor-inhibitory derivative, BE-10988, was studied in Streptomyces sp . BA10988 by… Expand
Highly Cited
2002
Highly Cited
2002
o-Imidoquinones, a rather rare class of compounds, are prepared from anilides by the action of Dess-Martin periodinane (DMP) and… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • figure 3
1991
1991
A new topoisomerase inhibitor, BE-10988, was isolated from the culture broth of a strain of actinomycetes. The producing strain… Expand
  • figure 2
  • table 1
  • table 2
  • table 3
  • figure 3